Cannabis

Why Join our monthly Salons:

 

  • Participate in interactive session for brainstorming with experts and peers
  • Access recordings of sessions for revisiting key points
  • Choose from multiple round table discussions every month
  • Gain concrete take-aways for immediate implementation

Learning By Conversation

Monthly Schedule

January: Discussion on Politics of Cannabis Treatment

  • Discuss the cannabis plant and what it contains
  • Explain opportunities for pharmacies
  • Review where you can find Cannabinoid Education – Source

February: Utilizing Cannabis as A Therapy for Chronic Pain Management

  • Understand the difference and medical benefits of THC vs CBD
  • Learn how to identify effective off the shelf products
  • Examine established protocols for pain management and dosing
  • Address arguments against cannabis for pain management

March: Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC, Delta 9 THC, Delta 10 THC

  • Review ways to talk to patients and medical professionals on differences between Delta 8, 9 and 10
  • Asses if there is a need for the different deltas being developed into specific and targeted applications
  • Identify a wish list of what policymakers should know about Delta 8, 9, and 10?

April: Different Q/A Thresholds In Different State Markets

  • Initial and Current State of Q/A Testing
  • State to State Variance
  • Transition to a Consistent, Federally Regulated Q/A Testing Program

May: Improving Patient Accessibility While Mitigating Black Market Appeal

  • Examine how price and supply are driving factors in accessibility pain points
  • Look at how civil rights is negatively effecting veterans and patients
  • Demonstrate government stigma and the consequences

June: Risks to Patients that Need to Be Considered

  • Examine potential criminal, civil and employment consequences to patients when things go wrong
  • Review negative impact of THC and CBD on certain patient populations and how to avoid them
  • Examine potential interactions and side effects of medicines

July: Using Data from State Prescription Drug Management Program To Show Reduction On Opioid Use In Lieu Of Cannabis

TBA

Who Should Attend

Quality Assurance General Counsel
Quality Control Pharmacy Services
Pharmacy Operations Facilities Management
Owner / President / CEO Supervising pharmacist or non-pharmacist manager equivalent
Compliance Facility manager
Policy and Regulatory Affairs Infection control lead
Legal Process improvement

Industries

503A Compounding Pharmacies Community Pharmacies
503B Compounding Pharmacies Specialty Pharmacies
Hospital Pharmacies Nuclear Pharmacies
Cannabis Pharmacogenomics
Compounding Pharmacies PodcastSign up for weekly alerts to latest episodes